Phenomics Health Inc. , a precision medicine company based on the bioinformatics platform, today announced that it has acquired Precera Bioscience, based in Franklin, Tennessee, USA. Patented drug metabolome technology portfolio. Phenomics Health plans to integrate this new technology with its patented advanced drug genomics platform to provide healthcare providers with a more complete picture than the prior art in terms of patient potential and actual response to medication. The patented drug metabolome technology will be promoted under the PrecīsMed brand and licensed to clinical laboratories and healthcare systems to enable the detection, quantification and comprehensive evaluation of more than 200 drugs in the patient's bloodstream. The information generated by PrecīsMed in conjunction with Phenomics Health's technology will help clinicians determine what drugs and doses they are actually taking (whether prescription drugs or not), drug interactions, and how genetics affects body metabolism. The ability of drugs to treat individualized drugs.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!